467 related articles for article (PubMed ID: 16624928)
1. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
Feldmann M; Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis.
Little MA; Bhangal G; Smyth CL; Nakada MT; Cook HT; Nourshargh S; Pusey CD
J Am Soc Nephrol; 2006 Jan; 17(1):160-9. PubMed ID: 16306166
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasm-associated glomerulonephritis.
Morgan MD; Harper L; Williams J; Savage C
J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
Huugen D; Tervaert JW; Heeringa P
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
[TBL] [Abstract][Full Text] [Related]
6. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
7. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis.
Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1221-3. PubMed ID: 16624927
[No Abstract] [Full Text] [Related]
8. Potential target of infliximab in autoimmune and inflammatory diseases.
Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
[TBL] [Abstract][Full Text] [Related]
9. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Sfikakis PP
Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
[TBL] [Abstract][Full Text] [Related]
10. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
[TBL] [Abstract][Full Text] [Related]
11. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
12. [New insights in the treatment of ANCA-associated systemic vasculitis].
Sinico RA; Sabadini E
G Ital Nefrol; 2006; 23(2):138-48. PubMed ID: 16710819
[TBL] [Abstract][Full Text] [Related]
13. Current state of biologicals in the management of systemic vasculitis.
Lamprecht P; Till A; Steinmann J; Aries PM; Gross WL
Ann N Y Acad Sci; 2007 Sep; 1110():261-70. PubMed ID: 17911441
[TBL] [Abstract][Full Text] [Related]
14. [A case with rheumatoid arthritis complicated with ANCA-associated vasculitis].
Amano K; Nakabayashi K; Tsuzaka K; Takeuchi T; Koide J; Abe T; Matsumura O
Ryumachi; 1998 Oct; 38(5):741-6. PubMed ID: 9852752
[TBL] [Abstract][Full Text] [Related]
15. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
16. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
Atzeni F; Sarzi-Puttini P; Doria A; Iaccarino L; Capsoni F
Autoimmun Rev; 2005 Mar; 4(3):144-52. PubMed ID: 15823500
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?
McAdoo SP; Pusey CD
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i80-i88. PubMed ID: 28391344
[TBL] [Abstract][Full Text] [Related]
18. Animal models of systemic vasculitis.
Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
[TBL] [Abstract][Full Text] [Related]
19. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
Wiik A; Brimnes J; Heegaard NH
Isr Med Assoc J; 1999 Sep; 1(1):4-7. PubMed ID: 11370121
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
Bosch X; Guilabert A; Espinosa G; Mirapeix E
Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
